Craft
  • Home
  •  / NATCO Pharma
NATCO Pharma

NATCO Pharma

Revenue

₹19 B

FY, 2022

Market Capitalization

₹117.6 B

2022-09-20

NATCO Pharma Summary

Company summary

Overview
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). It specializes in generic oncology.
Type
Public
Founded
1981
HQ
Hyderabad, IN | view all locations
Website
https://www.natcopharma.co.in/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • V.c Nannapaneni

    V.c Nannapaneni, Chairman & Managing Director

    • Rajeev Nannapaneni

      Rajeev Nannapaneni, Vice Chairman & CEO

      • M. Pulla Reddy

        M. Pulla Reddy, Executive Vice President - R&D

        • Leela Digumarti

          Leela Digumarti, Independent Director

          LocationsView all

          7 locations detected

          • Hyderabad, Telangana HQ

            India

            Natco House, Road No-2, Banjara Hills, Park View Enclave, Jubilee Hills

          • Central Hope Town, UK

            India

            Pharma City Rd

          • Chennai, TN

            India

            Tpp salai, 74/7b, SH 104, Vaikkadu, Block 270 Manali New Town, Manali

          • Hyderabad, TG

            India

            Unnamed Road, Sanath Nagar IE, Sanath Nagar

          • Santola, AS

            India

            Mirza Chowk, Mirza

          • Vijayapuri North, TG

            India

            H8M7+X6P

          and 1 others

          NATCO Pharma Financials

          Summary financials

          Revenue (Q1, 2023)
          ₹8.8B
          Gross profit (Q1, 2023)
          ₹7.7B
          Net income (Q1, 2023)
          ₹3.2B
          EBIT (Q1, 2023)
          ₹3.9B
          Enterprise value
          $117.6B

          Footer menu